August 09,2007
Grassley Seeks FDA Briefing on Steps to Ensure Safety of Foreign-made Medicine
WASHINGTON – Sen. Chuck Grassley, ranking member of the Committee on Finance, is asking the Food and Drug Administration for an explanation of its steps to ensure the safety of foreign-made medicine. In a letter to the agency commissioner, Grassley said he is disturbed by reports of the inadequacy of FDA inspections of foreign pharmaceutical manufacturing facilities, especially given the growing predominance of overseas manufacturing of such products.
The text of Grassley’s letter follows here.
###
Next Article Previous Article
Recent News
- Wyden Hearing Statement at Trade Agenda Hearing
- Wyden Statement at Finance Committee Hearing on IRS Direct File and Continued Improvements to Customer Service
- State Attorneys General Misused Medicaid Authority to Persecute Teens Seeking Gender Affirming Care, Finance Inquiry Finds; Politicized Requests for Patient Information Caused Spike in Teen Crisis Mental Health Calls
- Wyden Calls on Senate to Pass Bipartisan Tax Bill, Says Kids & Small Businesses Cannot Wait on Senate Republicans
- Wyden Statement on Looming Small Business Failures if Senate Republicans Block the Tax Relief for American Families and Workers Act
